The Age of Human Augmentation

For decades, human augmentation belonged largely to the realm of science fiction. Neural implants, cybernetic limbs, genetically engineered humans and visions of transhumanism felt distant, speculative and, for most people, irrelevant.

At the fringes of technology conferences, there were people who had implanted RFID chips beneath their skin, evangelising about a coming cyborg future. But it all felt less like the beginning of a societal transformation and more like a niche subculture somewhere between body modification and performance art.

Our transhuman future has now arrived, and in a very different package to the one that was predicted – it has burst into the mainstream in the form or weight-loss injections and chatbots.

Today, millions of people use GLP-1 therapies to alter appetite, eating behaviour and impulse control. Millions more use AI tools to augment writing, analysis, creativity and decision-making. If we include the AI features now embedded into search engines, productivity software and consumer platforms, the number rises into the billions.

These technologies have reached mainstream scale remarkably quickly, but it is their mode of action that is more interesting. Both reach into capabilities that have traditionally been considered intrinsic to the human experience. GLP-1 therapies influence biological drives that were once managed through willpower and AI systems increasingly assist with activities that previously relied on cognition, judgement, creativity and knowledge. Both offer meaningful benefits. Both have generated intense public debate. And both are beginning to reshape culture in ways that are not yet fully understood.

Society has spent decades imagining a future in which humans would be augmented by technology. What is striking is how quotidian this first wave of augmentation has become.

The Cyborg Theocracy

One reason GLP-1 therapies have generated such fascination is that they blur the line between treatment and enhancement. They are approved for specific medical conditions, yet much of the public conversation revolves around something else entirely. Weight loss is not simply a health outcome. It carries social, cultural and economic value. It shapes how people are perceived by others and how they perceive themselves.

AI tools occupy a similar space. They are often described as productivity software, but many users experience them as something closer to cognitive augmentation. They help people write more effectively, analyse information more quickly, generate ideas and perform tasks that previously required specialist expertise. This feels fundamentally different from previous waves of technology change – these are not tools helping people do something. They are helping people become something.

The writer Mary Harrington has described this emerging reality as a "cyborg theocracy". The phrase is intentionally provocative. Her argument is not simply that technology is becoming more powerful, but that a new belief system is emerging around human optimisation itself.

In this worldview, human limitations are increasingly seen as problems to be solved. Biological drives, cognitive constraints, physical imperfections and even emotional challenges become candidates for technological intervention. More importantly, the institutions shaping modern life - governments, healthcare systems, technology companies, employers, universities and professional bodies - often act as advocates for these interventions. Like a priesthood interpreting religious doctrine, they define what constitutes progress, encourage adoption and increasingly shape the incentives that determine who participates and who does not.

If a weight-loss drug allows people to achieve outcomes that were previously difficult, does declining to use it become a lifestyle choice or a disadvantage? If AI allows workers to produce better outputs in less time, does using it remain optional, or does it become a baseline expectation of professional competence? If a company expects employees to use AI tools to remain productive, is that fundamentally different from expecting them to use email or spreadsheets? What begins as an opportunity to enhance capability could slide quickly towards an expectation, leaving those who choose not to participate increasingly swimming against the tide.

The New Fault Line

What makes this moment particularly interesting is that resistance to augmentation is emerging at the same time as adoption accelerates. Recent examples of graduating students booing commencement speakers discussing AI are revealing. The reaction is not simply about concerns over technology and its effect on the graduate jobs market. It potentially reflects a deeper unease about what happens when technology begins to influence outcomes that we traditionally associate with human effort, skill and achievement. Similar tensions are emerging around GLP-1 therapies. Supporters see them as a breakthrough that helps people overcome biological tendencies poorly suited to modern environments. Critics see them as a shortcut.

Historically, the major divisions in society have been framed around politics, geography, economics or generation. The coming decade may introduce a different kind of fault line: between those who embrace augmentation and those who resist it.

Some people will view these technologies as tools for self-improvement, empowerment and progress. Others will see them as inauthentic, unfair or socially corrosive. These attitudes are unlikely to be distributed evenly. They may align with age, profession, education, socioeconomic status and cultural values.

What Does This Mean for Business?

For business leaders, the question is no longer whether human augmentation technologies will arrive. They are already here. The challenge is understanding how they reshape expectations of performance, achievement and wellbeing for both employees and customers.

For employees, organisations will need to decide where they stand on augmentation in the workplace. If AI tools enable employees to produce better work in less time, is their use encouraged, expected or optional? How should performance be assessed when some people embrace augmentation and others resist it? At what point does refusing to use AI become equivalent to refusing to use email, spreadsheets or search engines?

The challenge extends beyond productivity. As AI becomes embedded in knowledge work, organisations will need to think carefully about how they preserve and reward distinctly human capabilities such as judgement, creativity, critical thinking and empathy. In an augmented workplace, contribution will increasingly be measured not by what people produce alone, but by how effectively they collaborate with intelligent systems.

For customers, a different set of questions emerges. Healthcare organisations are already grappling with the implications of GLP-1 therapies for treatment pathways, patient support and public health. Beyond healthcare, businesses will increasingly encounter customers whose expectations, behaviours and decision-making processes are shaped by AI assistants acting on their behalf.

More fundamentally, organisations may find themselves under pressure to articulate their broader philosophy towards human augmentation. Some brands will position themselves as pro-augmentation, helping customers and employees maximise their capabilities through technology. Others may seek to differentiate themselves through organic, human-first principles, emphasising authenticity, human expertise and limits on automation.

Just as businesses have been expected to develop positions on sustainability, diversity and responsible innovation, they will increasingly be expected to explain how they approach technologies that alter human capabilities themselves.